Annual Meeting

A good place to live and to study cancer

Jason Liu
By Jason Liu
Oct. 27, 2023

After completing my postdoctoral training at the University of California, San Diego, I received an attractive offer to work in San Antonio. I am now an associate professor in the molecular medicine department at the University of Texas Health Science Center at San Antonio.

Dynamic control of enhancer repertoires drives stage-specific transcription during tissue development and disease progression. My lab’s overall objective is to gain a fundamental understanding of the regulations of enhancer dynamics in response to signaling and their effects on gene regulation, leading to innovative approaches to prevent and treat enhancer-related diseases, especially cancers.

I wanted to work in this city for several reasons. First, Texas offers substantial start-up funding for researchers across various disciplines to study cancer. As a new PI who recently concluded postdoctoral training and was recruited as a tenure-track faculty member, I received a $2 million start-up grant from the Cancer Prevention and Research Institute of Texas, known as CPRIT. Also, San Antonio is a military city and many people choose to stay after retiring. This ensures abundant clinical resources for researching aging and cancer.

San Antonio also has historical significance and is a vibrant tourist destination, with attractions such as the River Walk and the Alamo. As the seventh-largest city in the U.S., San Antonio offers the advantages of a major urban center while providing a high quality of life due to its affordability and favorable traffic conditions.

My wife is also a PI, researching neuronal diseases. She and I have been immensely content working and living in San Antonio since we moved here from San Diego. Our two young daughters find a lot of fun things to do in this city. Besides working hard in the lab, we often take our daughters out to eat good food, visit the attractions and play at the SeaWorld or Six Flags amusement parks on weekends.  

Submit an abstract

Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, will be held March 23–26 in San Antonio. Abstracts for poster presentations and spotlight talks will be accepted through Nov. 30. See the poster categories and spotlight talk themes.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jason Liu
Jason Liu

Jason Liu is an associate professor in the molecular medicine department at the University of Texas Health Science Center at San Antonio.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Exploring the link between lipids and longevity
Profile

Exploring the link between lipids and longevity

Jan. 2, 2026

Meng Wang will present her work on metabolism and aging at the ASBMB Annual Meeting, March 7-10, just outside of Washington, D.C.

Defining a ‘crucial gatekeeper’ of lipid metabolism
Award

Defining a ‘crucial gatekeeper’ of lipid metabolism

Dec. 31, 2025

George Carman receives the Herbert Tabor Research Award at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Nuñez receives Vallee Scholar Award
Member News

Nuñez receives Vallee Scholar Award

Dec. 29, 2025

He will receive $400,000 to support his research.

Mydy named Purdue assistant professor
Member News

Mydy named Purdue assistant professor

Dec. 22, 2025

Her lab will focus on protein structure and function, enzyme mechanisms and plant natural product biosynthesis, working to characterize and engineer plant natural products for therapeutic and agricultural applications.

In memoriam: Michael J. Chamberlin
In Memoriam

In memoriam: Michael J. Chamberlin

Dec. 15, 2025

He discovered RNA polymerase and was an ASBMB member for nearly 60 years.

Building the blueprint to block HIV
Profile

Building the blueprint to block HIV

Dec. 11, 2025

Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.